{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:29:41Z","timestamp":1787509781358,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- INDIGO CONSORTIUM","award":["BT\/IN\/EU-INF\/17\/GK\/2019-20"],"award-info":[{"award-number":["BT\/IN\/EU-INF\/17\/GK\/2019-20"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"Department of Biotechnology (DBT)- National Institutes of Health","award":["BT\/PR30219\/MED\/15\/189\/2018"],"award-info":[{"award-number":["BT\/PR30219\/MED\/15\/189\/2018"]}]},{"name":"DBT-BioCARe, Govt of India","award":["BT\/PR50853\/BIC\/101\/1314\/2023"],"award-info":[{"award-number":["BT\/PR50853\/BIC\/101\/1314\/2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01331-6","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:36:54Z","timestamp":1766749014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunity"],"prefix":"10.1038","volume":"11","author":[{"given":"Hima","family":"Bindhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srabanti","family":"Rakshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasista","family":"Adiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirutha Chetan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Macrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweety","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Sasidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Vyakarnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"1331_CR1","unstructured":"National Centre for disease control. Ministry of Health and Family Welfare Directorate General of Health Services, Government of India. Seasonal influenza. State\/UT-wise, Year-wise number of cases and deaths from 2018\u20132024. https:\/\/ncdc.mohfw.gov.in\/wp-content\/uploads\/2024\/12\/Seasonal-Influenza-A-31.10.2024.pdf"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/lungindia.lungindia_270_20","volume":"37","author":"R Dhar","year":"2020","unstructured":"Dhar, R. et al. Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults. Lung India 37, 4 (2020).","journal-title":"Lung India"},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev-virology-010320-044746","volume":"7","author":"S Gouma","year":"2020","unstructured":"Gouma, S., Anderson, E. M. & Hensley, S. E. Challenges of making effective influenza vaccines. Annu. Rev. Virol. 7, 495\u2013512 (2020).","journal-title":"Annu. Rev. Virol."},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S2213-2600(22)00266-1","volume":"11","author":"E Jones-Gray","year":"2022","unstructured":"Jones-Gray, E., Robinson, E. J., Kucharski, A. J., Fox, A. & Sullivan, S. G. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis. Lancet Respir. Med. 11, 27\u201344 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1331_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003609","volume":"18","author":"A Krishnan","year":"2021","unstructured":"Krishnan, A. et al. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial. PLoS Med. 18, e1003609 (2021).","journal-title":"PLoS Med."},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2021.1885278","volume":"18","author":"I Basu","year":"2021","unstructured":"Basu, I. et al. Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India\u2014a phase III, active-controlled, randomized clinical study. Hum. Vaccin. Immunother. 18, 1\u201310 (2021).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1331_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson, T. M. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274\u2013280 (2012).","journal-title":"Nat. Med."},{"key":"1331_CR9","doi-asserted-by":"publisher","unstructured":"Janssens, Y. et al. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front. Immunol. 13, https:\/\/doi.org\/10.3389\/fimmu.2022.959379 (2022).","DOI":"10.3389\/fimmu.2022.959379"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiz433","volume":"222","author":"KA Richards","year":"2019","unstructured":"Richards, K. A. et al. Evidence that blunted CD4 T-Cell responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects. J. Infect. Dis. 222, 273\u2013277 (2019).","journal-title":"J. Infect. Dis."},{"key":"1331_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/eji.201847852","volume":"49","author":"E Gage","year":"2018","unstructured":"Gage, E. et al. Coler, Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization. Eur. J. Immunol. 49, 266\u2013276 (2018).","journal-title":"Eur. J. Immunol."},{"key":"1331_CR12","doi-asserted-by":"publisher","unstructured":"Brown, D. M., Lampe, A. T. & Workman, A. M. The differentiation and protective function of cytolytic CD4 T cells in influenza infection. Front. Immunol. 7 https:\/\/doi.org\/10.3389\/fimmu.2016.00093 (2016).","DOI":"10.3389\/fimmu.2016.00093"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"114259","DOI":"10.1016\/j.celrep.2024.114259","volume":"43","author":"S Hulin-Curtis","year":"2024","unstructured":"Hulin-Curtis, S. et al. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. Cell Rep. 43, 114259 (2024).","journal-title":"Cell Rep."},{"key":"1331_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41385-018-0004-9","volume":"11","author":"P-H Lin","year":"2018","unstructured":"Lin, P.-H. et al. Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection. Mucosal Immunol. 11, 1239\u20131253 (2018).","journal-title":"Mucosal Immunol."},{"key":"1331_CR15","doi-asserted-by":"publisher","unstructured":"Lin, P. et al. Association of vaccine-specific regulatory T cells with reduced antibody response to repeated influenza vaccination. Eur. J. Immunol. 53, https:\/\/doi.org\/10.1002\/eji.202350525 (2023).","DOI":"10.1002\/eji.202350525"},{"key":"1331_CR16","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.4049\/jimmunol.1203140","volume":"190","author":"EL Brincks","year":"2013","unstructured":"Brincks, E. L. et al. Woodland, antigen-specific memory regulatory CD4+FOXP3+ T cells control memory responses to influenza virus infection. J. Immunol. 190, 3438\u20133446 (2013).","journal-title":"J. Immunol."},{"key":"1331_CR17","doi-asserted-by":"publisher","unstructured":"Riese, P. et al. Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly. Nat. Commun. 13, https:\/\/doi.org\/10.1038\/s41467-022-34487-z (2022).","DOI":"10.1038\/s41467-022-34487-z"},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2019.02.007","volume":"59","author":"H Ueno","year":"2019","unstructured":"Ueno, H. Tfh cell response in influenza vaccines in humans: what is visible and what is invisible. Curr. Opin. Immunol. 59, 9\u201314 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"1331_CR19","doi-asserted-by":"publisher","unstructured":"Le\u00f3n, B., Bradley, J. E., Lund, F. E., Randall, T. D. & Ballesteros-Tato, A. FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat. Commun. 5, https:\/\/doi.org\/10.1038\/ncomms4495 (2014).","DOI":"10.1038\/ncomms4495"},{"key":"1331_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/imcb.12271","volume":"97","author":"C Lu","year":"2019","unstructured":"Lu, C. et al. Memory regulatory T cells home to the lung and control influenza A virus infection. Immunol. Cell Biol. 97, 774\u2013786 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ni.3224","volume":"16","author":"BJ Laidlaw","year":"2015","unstructured":"Laidlaw, B. J. et al. Production of IL-10 by CD4+ regulatory T cells during the resolution of infection promotes the maturation of memory CD8+ T cells. Nat. Immunol. 16, 871\u2013879 (2015).","journal-title":"Nat. Immunol."},{"key":"1331_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imm.12734","volume":"151","author":"M Bhattacharyya","year":"2017","unstructured":"Bhattacharyya, M. & Penaloza-MacMaster, P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology 151, 340\u2013348 (2017).","journal-title":"Immunology"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.1227049","volume":"338","author":"L Pace","year":"2012","unstructured":"Pace, L. et al. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 338, 532\u2013536 (2012).","journal-title":"Science"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/pathogens12020169","volume":"12","author":"SM King","year":"2023","unstructured":"King, S. M., Bryan, S. P., Hilchey, S. P., Wang, J. & Zand, M. S. First impressions matter: immune imprinting and Antibody Cross-Reactivity in influenza and SARS-COV-2. Pathogens 12, 169 (2023).","journal-title":"Pathogens"},{"key":"1331_CR25","doi-asserted-by":"publisher","unstructured":"Chaisawangwong, W. et al. Cross-reactivity of SARS-CoV-2\u2013 and influenza A\u2013specific T cells in individuals exposed to SARS-CoV-2. JCI Insight 7, https:\/\/doi.org\/10.1172\/jci.insight.158308 (2022).","DOI":"10.1172\/jci.insight.158308"},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41586-022-05670-5","volume":"614","author":"R Sparks","year":"2023","unstructured":"Sparks, R. et al. Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19. Nature 614, 752\u2013761 (2023).","journal-title":"Nature"},{"key":"1331_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8028725","volume":"2019","author":"P Lamichhane","year":"2019","unstructured":"Lamichhane, P. & Samarasinghe, A. E. The role of Innate Leukocytes during Influenza Virus Infection. J. Immunol. Res. 2019, 1\u201317 (2019).","journal-title":"J. Immunol. Res."},{"key":"1331_CR28","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1128\/JVI.05685-11","volume":"86","author":"RJ Betts","year":"2011","unstructured":"Betts, R. J. et al. Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated FOXP3 + regulatory T cell response. J. Virol. 86, 2817\u20132825 (2011).","journal-title":"J. Virol."},{"key":"1331_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2016.09.050","volume":"167","author":"P Bacher","year":"2016","unstructured":"Bacher, P. et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell 167, 1067\u20131078.e16 (2016).","journal-title":"Cell"},{"key":"1331_CR30","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/mi.2013.107","volume":"7","author":"P Bacher","year":"2013","unstructured":"Bacher, P. et al. Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol. 7, 916\u2013928 (2013).","journal-title":"Mucosal Immunol."},{"key":"1331_CR31","doi-asserted-by":"publisher","unstructured":"Nowak, A. et al. CD137+CD154\u2014expression as a regulatory T Cell (Treg)-specific activation signature for identification and sorting of stable human Tregs from in vitro expansion cultures. Front. Immunol. 9, https:\/\/doi.org\/10.3389\/fimmu.2018.00199 (2018).","DOI":"10.3389\/fimmu.2018.00199"},{"key":"1331_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108441","volume":"26","author":"NM Almaz\u00e1n","year":"2023","unstructured":"Almaz\u00e1n, N. M. et al. Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics. iScience 26, 108441 (2023).","journal-title":"iScience"},{"key":"1331_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/vaccines12040425","volume":"12","author":"A Riccomi","year":"2024","unstructured":"Riccomi, A. et al. Effects of influenza vaccine on the immune responses to SARS-COV-2 vaccination. Vaccines 12, 425 (2024).","journal-title":"Vaccines"},{"key":"1331_CR34","doi-asserted-by":"publisher","unstructured":"Rakshit, S. et al. Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELDTM vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults. Front. Immunol. 13, https:\/\/doi.org\/10.3389\/fimmu.2022.985938 (2022).","DOI":"10.3389\/fimmu.2022.985938"},{"key":"1331_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107889","volume":"26","author":"A Ahmed","year":"2023","unstructured":"Ahmed, A. et al. Vyakarnam, BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways. iScience 26, 107889 (2023).","journal-title":"iScience"},{"key":"1331_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.chom.2023.05.004","volume":"31","author":"MG Netea","year":"2023","unstructured":"Netea, M. G. et al. The role of trained immunity in COVID-19: lessons for the next pandemic. Cell Host Microbe 31, 890\u2013901 (2023).","journal-title":"Cell Host Microbe"},{"key":"1331_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41556-021-00690-1","volume":"23","author":"M You","year":"2021","unstructured":"You, M. et al. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19. Nat. Cell Biol. 23, 620\u2013630 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1331_CR38","doi-asserted-by":"publisher","unstructured":"Kothari, K. et al. A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months. Hum. Vaccin. Immunother. 20, https:\/\/doi.org\/10.1080\/21645515.2024.2416329 (2024).","DOI":"10.1080\/21645515.2024.2416329"},{"key":"1331_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/vaccines12091036","volume":"12","author":"V D\u2019Onofrio","year":"2024","unstructured":"D\u2019Onofrio, V. et al. Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study. Vaccines 12, 1036 (2024).","journal-title":"Vaccines"},{"key":"1331_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/14760584.2018.1541407","volume":"17","author":"D Korenkov","year":"2018","unstructured":"Korenkov, D., Isakova-Sivak, I. & Rudenko, L. Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine. Expert Rev. Vaccines 17, 977\u2013987 (2018).","journal-title":"Expert Rev. Vaccines"},{"key":"1331_CR41","doi-asserted-by":"publisher","unstructured":"Dantzler, K. W., de la Parte, L., & Jagannathan, P. Emerging role of \u03b3\u03b4 T cells in vaccine-mediated protection from infectious diseases. Clin. Transl. Immunol. 8, https:\/\/doi.org\/10.1002\/cti2.1072 (2019).","DOI":"10.1002\/cti2.1072"},{"key":"1331_CR42","doi-asserted-by":"publisher","unstructured":"Driver, J. P., de Carvalho Madrid, D. M., Gu, W., Artiaga, B. L. & Richt, J. A. Modulation of immune responses to influenza A virus vaccines by natural killer T cells. Front. Immunol. 11, https:\/\/doi.org\/10.3389\/fimmu.2020.02172 (2020).","DOI":"10.3389\/fimmu.2020.02172"},{"key":"1331_CR43","doi-asserted-by":"publisher","unstructured":"Kazmin, D. et al. Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children. Npj Vaccines 8, https:\/\/doi.org\/10.1038\/s41541-023-00702-1 (2023).","DOI":"10.1038\/s41541-023-00702-1"},{"key":"1331_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imm.13620","volume":"169","author":"A Dutta","year":"2022","unstructured":"Dutta, A. et al. The origin of regulatory from the effector cells in LAG-3-marked Th1 immunity against severe influenza virus infection. Immunology 169, 167\u2013184 (2022).","journal-title":"Immunology"},{"key":"1331_CR45","doi-asserted-by":"publisher","unstructured":"Alvarez, F. & Piccirillo, C. A. The functional adaptation of effector Foxp3+ regulatory T cells to pulmonary inflammation. Eur. J. Immunol. 53, https:\/\/doi.org\/10.1002\/eji.202250273 (2023).","DOI":"10.1002\/eji.202250273"},{"key":"1331_CR46","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.4049\/jimmunol.1203302","volume":"190","author":"F Bedoya","year":"2013","unstructured":"Bedoya, F. et al. Viral antigen induces differentiation of FOXP3+ natural regulatory T cells in influenza Virus\u2013Infected mice. J. Immunol. 190, 6115\u20136125 (2013).","journal-title":"J. Immunol."},{"key":"1331_CR47","doi-asserted-by":"publisher","unstructured":"Kaiser, K. A. et al. Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells. J. Exp. Med. 220, https:\/\/doi.org\/10.1084\/jem.20221462 (2022).","DOI":"10.1084\/jem.20221462"},{"key":"1331_CR48","doi-asserted-by":"publisher","first-page":"e75148","DOI":"10.1371\/journal.pone.0075148","volume":"8","author":"MA Schijf","year":"2013","unstructured":"Schijf, M. A. et al. Alterations in regulatory T cells induced by specific oligosaccharides improve vaccine responsiveness in mice. PLoS ONE 8, e75148 (2013).","journal-title":"PLoS ONE"},{"key":"1331_CR49","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1080\/21645515.2020.1793711","volume":"16","author":"H Jang","year":"2020","unstructured":"Jang, H. et al. Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge. Hum. Vaccin. Immunother. 16, 2042\u20132050 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1331_CR50","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.4161\/hv.36134","volume":"10","author":"AS De Groot","year":"2014","unstructured":"De Groot, A. S. et al. Immune camouflage: relevance to vaccines and human immunology. Hum. Vaccin. Immunother. 10, 3570\u20133575 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1331_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126670","volume":"46","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice. Vaccine 46, 126670 (2024).","journal-title":"Vaccine"},{"key":"1331_CR52","doi-asserted-by":"publisher","unstructured":"Kelvin, A. A. & Zambon, M. Influenza imprinting in childhood and the influence on vaccine response later in life. Euro Surveill. 24, https:\/\/doi.org\/10.2807\/1560-7917.es.2019.24.48.1900720 (2019).","DOI":"10.2807\/1560-7917.es.2019.24.48.1900720"},{"key":"1331_CR53","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41564-024-01732-8","volume":"9","author":"P Edler","year":"2024","unstructured":"Edler, P. et al. Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nat. Microbiol. 9, 2073\u20132083 (2024).","journal-title":"Nat. Microbiol."},{"key":"1331_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4049\/jimmunol.1801149","volume":"202","author":"A Zhang","year":"2019","unstructured":"Zhang, A., Stacey, H. D., Mullarkey, C. E. & Miller, M. S. Original antigenic sin: how first exposure shapes lifelong anti\u2013Influenza virus immune responses. J. Immunol. 202, 335\u2013340 (2019).","journal-title":"J. Immunol."},{"key":"1331_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/infdis\/jiz543","volume":"221","author":"B Flannery","year":"2019","unstructured":"Flannery, B. et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018\u20132019 season. J. Infect. Dis. 221, 8\u201315 (2019).","journal-title":"J. Infect. Dis."},{"key":"1331_CR56","doi-asserted-by":"publisher","unstructured":"Christensen, S. R., Martin, E. T., Petrie, J. G., Monto, A. S. & Hensley, S. E. The 2009 pandemic H1N1 hemagglutinin stalk remained antigenically stable after circulating in humans for a decade. J. Virol. 96, https:\/\/doi.org\/10.1128\/jvi.02200-21 (2022).","DOI":"10.1128\/jvi.02200-21"},{"key":"1331_CR57","doi-asserted-by":"publisher","unstructured":"Valesano, A. L. et al. Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts. J. Virol. 94, https:\/\/doi.org\/10.1128\/jvi.01710-19 (2019).","DOI":"10.1128\/jvi.01710-19"},{"key":"1331_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101022","volume":"44","author":"J Nazareth","year":"2024","unstructured":"Nazareth, J. et al. Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study. Lancet Reg. Health Eur. 44, 101022 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"1331_CR59","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","volume":"398","author":"R Lazarus","year":"2021","unstructured":"Lazarus, R. et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet 398, 2277\u20132287 (2021).","journal-title":"Lancet"},{"key":"1331_CR60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S2213-2600(21)00557-9","volume":"10","author":"R Izikson","year":"2022","unstructured":"Izikson, R. et al. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged \u226565 years: a phase 2, randomised, open-label study. Lancet Respir. Med. 10, 392\u2013402 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1331_CR61","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmi.2022.12.008","volume":"29","author":"H Radner","year":"2022","unstructured":"Radner, H. et al. Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers. Clin. Microbiol. Infect. 29, 635\u2013641 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1331_CR62","doi-asserted-by":"publisher","unstructured":"Barouch, S. E. et al. Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses. bioRxiv (Cold Spring Harbor Laboratory), https:\/\/doi.org\/10.1101\/2023.09.12.557347 (2023).","DOI":"10.1101\/2023.09.12.557347"},{"key":"1331_CR63","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1038\/s41590-024-01970-2","volume":"25","author":"S Cobey","year":"2024","unstructured":"Cobey, S. Vaccination against rapidly evolving pathogens and the entanglements of memory. Nat. Immunol. 25, 2015\u20132023 (2024).","journal-title":"Nat. Immunol."},{"key":"1331_CR64","doi-asserted-by":"publisher","unstructured":"Olafsdottir, T. A. et al. Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects. Front. Immunol. 8, https:\/\/doi.org\/10.3389\/fimmu.2017.01872 (2018).","DOI":"10.3389\/fimmu.2017.01872"},{"key":"1331_CR65","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1586\/14760584.2016.1164046","volume":"15","author":"CM Trombetta","year":"2016","unstructured":"Trombetta, C. M. & Montomoli, E. Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Rev. Vaccines 15, 967\u2013976 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"1331_CR66","doi-asserted-by":"publisher","unstructured":"Rakshit, S. et al. Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN\u00ae induced immunity in COVID-19 exposed Indians. Npj Vaccines 8, https:\/\/doi.org\/10.1038\/s41541-023-00731-w (2023).","DOI":"10.1038\/s41541-023-00731-w"},{"key":"1331_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007289","volume":"14","author":"A Ahmed","year":"2018","unstructured":"Ahmed, A. et al. Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis. PLoS Pathog. 14, e1007289 (2018).","journal-title":"PLoS Pathog."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01331-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:05:11Z","timestamp":1767985511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01331-6","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}